TY - JOUR T1 - Predicting gene expression level in <em>E. coli</em> from mRNA sequence information JF - bioRxiv DO - 10.1101/089102 SP - 089102 AU - Linlin Zhao AU - Nima Abedpour AU - Christopher Blum AU - Petra Kolkhof AU - Mathias Beller AU - Markus Kollmann AU - Emidio Capriotti Y1 - 2016/01/01 UR - http://biorxiv.org/content/early/2016/11/22/089102.abstract N2 - Motivation The accurate characterization of the translational mechanism is crucial for enhancing our understanding of the relationship between genotype and phenotype. In particular, predicting the impact of the genetic variants on gene expression will allow to optimize specific pathways and functions for engineering new biological systems. In this context, the development of accurate methods for predicting translation efficiency from the nucleotide sequence is a key challenge in computational biology.Methods In this work we present PGExpress, a binary classifier to discriminate between mRNA sequences with low and high translation efficiency in E. coli. PGExpress algorithm takes as input 12 features corresponding to RNA folding and anti-Shine-Dalgarno hybridization free energies. The method was trained on a set of 1,772 sequence variants (WT-High) of 137 essential E. coli genes. For each gene, we considered 13 sequence variants of the first 33 nucleotides encoding for the same amino acids followed by the superfolder GFP. Each gene variant is represented sequence blocks that include the Ribosome Binding Site (RBS), the first 33 nucleotides of the coding region (C33), the remaining part of the coding region (CC), and their combinations.Results Our logistic regression-based tool (PGExpress) was trained using a 20-fold gene-based cross-validation procedure on the WT-High dataset. In this test PGExpress achieved an overall accuracy of 74%, a Matthews correlation coefficient 0.49 and an Area Under the Receiver Operating Characteristic Curve (AUC) of 0.81. Tested on 3 sets of sequences with different Ribosome Binding Sites, PGExpress reaches similar AUC. Finally, we validated our method by performing in-house experiments on five newly generated mRNA sequence variants. The predictions of the expression level of the new variants are in agreement with our experimental results in E. coli.Availability http://folding.biofold.org/pgexpressContact markus.kollmann{at}hhu.de, emidio.capriotti{at}unibo.it ER -